Search
Royalty Pharma PLC
RPRXAdd to Watchlist
58.440USD
-0.580-0.98%
Close 07-31 16:00（ET）Quotes delayed by 15 min
25.93BMarket Cap
30.42P/E TTM
RPRX Financials
See Royalty Pharma PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Royalty Pharma PLC Earnings Date
Latest Release
Aug 5, 2026
EPS / Forecast
--/1.28
Revenue / Forecast
--/693.19M
Period
FY2025 Earnings
Revenue(YoY)
2.38B
5.06%
EPS(YoY)
1.79
-6.41%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its total revenue reached 2.38B, with a year-on-year change of 2.26B.
What are the current assets of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its current assets were 1.53B, with a year-on-year change of -15.21.
What are the total assets of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its total assets of Royalty Pharma PLC were 19.62B, with a year-on-year change of 7.67.
What are the total liabilities of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its total liabilities of Royalty Pharma PLC were 9.91B, with a year-on-year change of 25.70.
What is the total equity of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its total equity of Royalty Pharma PLC was 9.71B, with a year-on-year change of -6.07.
What is the net operating income of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its net operating income of Royalty Pharma PLC was 1.56B, with a year-on-year change of 20.66.
What is the net investment of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its net investment of Royalty Pharma PLC was -1.61B, with a year-on-year change of 39.73.
What is the net financing of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its net financing of Royalty Pharma PLC was -1.19B, with a year-on-year change of -428.39.
What is the Earnings Per Share (EPS) of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its Earnings Per Share (EPS) was 1.79, with a year-on-year change of -6.41.
What is the net income of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its net income was 770.95M, with a year-on-year change of -10.25.
What is the net margin of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its net profit margin was 55.68, with a year-on-year change of -5.29.
What is the debt-to-asset ratio of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its debt-to-asset ratio was 45.62, with a year-on-year change of 9.20.
What is the Return on Equity (ROE) of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its Return on Equity (ROE) was 11.49, with a year-on-year change of -9.92.
What is the Return on Assets (ROA) of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its Return on Assets (ROA) was 7.00, with a year-on-year change of -9.01.
What is the operating profit of Royalty Pharma PLC?
According to Royalty Pharma PLC's FY2025 earnings report, its operating profit was 1.56B, with a year-on-year change of 20.66.